#MeetTheLab
This week, we are happy to introduce the Zitzmann Lab from @oxfordbiochemistry.bsky.social
The lab focuses on developing antiviral therapies to address #HepatitisB ( #HBV), #HepatitisC ( #HCV), human immunodeficiency virus ( #HIV), #DengueVirus ( #DENV), #Ebola, and #influenza.
This week, we are happy to introduce the Zitzmann Lab from @oxfordbiochemistry.bsky.social
The lab focuses on developing antiviral therapies to address #HepatitisB ( #HBV), #HepatitisC ( #HCV), human immunodeficiency virus ( #HIV), #DengueVirus ( #DENV), #Ebola, and #influenza.
Comments
🔹 HBV: 20 million new infections annually, with 400 million people living with chronic infections.
🔹 HCV: 3 million new infections annually, affecting 220 million chronically.
🔹 DENV: 390 million new infections annually.
In addition to these, global health threats like #Ebola and #influenza highlight the ongoing need for antiviral solutions.